March 15, 2024 · Form 4 insider transaction
Singleton Mark Leonard bought 80,610 shares of Bioventus Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.